# Reduction of Postherpetic Neuralgia in Herpes Zoster

> **NCT01250561** · NA · COMPLETED · sponsor: **Center for Clinical Studies, Texas** · enrollment: 133 (actual)

## Conditions studied

- Herpes Zoster
- Post-herpetic Neuralgia

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Valacyclovir

## Key facts

- **NCT ID:** NCT01250561
- **Lead sponsor:** Center for Clinical Studies, Texas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2010-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01250561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01250561, "Reduction of Postherpetic Neuralgia in Herpes Zoster". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01250561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
